BioLife Solns Q2 Adj EPS $(0.24) Misses $(0.20) Estimate, Sales $39.51M Miss $43.86M Estimate
Portfolio Pulse from bharat@benzinga.com
BioLife Solutions (NASDAQ:BLFS) reported Q2 losses of $(0.24) per share, missing the analyst consensus estimate of $(0.20) by 20%. This is an 84.62% decrease from the same period last year. The company also reported quarterly sales of $39.51 million, missing the analyst consensus estimate of $43.86 million by 9.92%. This is a 2.53% decrease from the same period last year.
August 08, 2023 | 8:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BioLife Solutions reported a larger than expected loss and lower than expected sales for Q2.
BioLife Solutions reported a larger than expected loss and lower than expected sales for Q2. This indicates potential financial challenges for the company, which could negatively impact the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100